Bionomics Ltd. ADR [NASDAQ: BNOX] loss -2.88% or -0.01 points to close at $0.19 with a heavy trading volume of 6569737 shares.
The daily chart for BNOX points out that the company has recorded -80.64% loss over the past six months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If we look at the average trading volume of 672.32K shares, BNOX reached to a volume of 6569737 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Bionomics Ltd. ADR [BNOX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BNOX shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BNOX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Bionomics Ltd. ADR shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 28, 2023. While these analysts kept the previous recommendation, Maxim Group dropped their target price from $7 to $10. The new note on the price target was released on September 28, 2023, representing the official price target for Bionomics Ltd. ADR stock. Previously, the target price had yet another raise to $54, while H.C. Wainwright analysts kept a Buy rating on BNOX stock.
The Average True Range (ATR) for Bionomics Ltd. ADR is set at 0.04 The Price to Book ratio for the last quarter was 0.22, with the Price to Cash per share for the same quarter was set at 0.64.
Trading performance analysis for BNOX stock
Bionomics Ltd. ADR [BNOX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.58. With this latest performance, BNOX shares dropped by -33.11% in over the last four-week period, additionally sinking by -80.64% over the last 6 months – not to mention a drop of -91.96% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BNOX stock in for the last two-week period is set at 30.88, with the RSI for the last a single of trading hit 30.86, and the three-weeks RSI is set at 31.70 for Bionomics Ltd. ADR [BNOX]. The present Moving Average for the last 50 days of trading for this stock 0.4517, while it was recorded at 0.1998 for the last single week of trading, and 0.7878 for the last 200 days.
Bionomics Ltd. ADR [BNOX]: A deeper dive into fundamental analysis
Bionomics Ltd. ADR’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.45 and a Current Ratio set at 3.45.
An analysis of Institutional ownership at Bionomics Ltd. ADR [BNOX]
The top three institutional holders of BNOX stocks are: ARMISTICE CAPITAL, LLC with ownership of 1.23 million shares, which is approximately 12.9314%. LYNX1 CAPITAL MANAGEMENT LP, holding 0.6 million shares of the stock with an approximate value of $$0.46 million in BNOX stocks shares; and LYNX1 CAPITAL MANAGEMENT LP, currently with $$0.24 million in BNOX stock with ownership which is approximately 3.331%.
